Announcements Trials
Browse Landscape

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Observational 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 21Lung Neoplasms 13Neoplasms 3Small Cell Lung Carcinoma 2Ovarian Neoplasms 2Adenocarcinoma of Lung 2Vulvar Neoplasms 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Stomach Neoplasms 1Small Cell Lung Cancer Extensive Stage 1Skin Neoplasms 1Rectal Neoplasms 1Pseudomyxoma Peritonei 1Prostatic Neoplasms 1Pneumonia 1Peritoneal Neoplasms 1Pathologic Complete Response 1Pancreatic Neoplasms 1Neoplasm Metastasis 1Mesothelioma 1Lymphoma 1Lung Diseases, Interstitial 1Liver Neoplasms 1Leukemia 1Laryngeal Neoplasms 1Kidney Neoplasms 1Head and Neck Neoplasms 1Gastrointestinal Neoplasms 1Frailty 1

Interventions

perflutren 1Thoracoscopy 1Surveys and Questionnaires 1Sulfur Hexafluoride 1Radiotherapy 1Prednisone 1Observation 1Lidocaine 1Health Records, Personal 1Drug Delivery Systems 1Dexamethasone 1Conscious Sedation 1Clinical Protocols 1Bronchoscopy 1Blood Pressure 1Adrenal Cortex Hormones 1Acetylcysteine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lung Diseases, Interstitial × Observation × Thoracic × Clear all
NCT06192004 2026-05-04

LOOP

AstraZeneca

Terminated
83 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Pneumonia, Lung Diseases, Interstitial

Data powered by HemOnc (CC BY 4.0) Colophon âš¡